rethinkPeptides Search
Menu
Research citation

Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors.

Pharmaceuticals (Basel, Switzerland), 18(11)

Citation

Leupe, Hannes; Cauwenbergh, Merel; Cleeren, Frederik; Dekervel, Jeroen; Verslype, Chris; Deroose, Christophe M. (2025). Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors.. Pharmaceuticals (Basel, Switzerland), 18(11). https://doi.org/10.3390/ph18111608